Summary: GE HealthCare and DeepHealth are partnering to enhance breast cancer screening and imaging efficiency by integrating DeepHealth’s AI-based SmartMammo workflow with GE’s Senographe Pristina system, providing improved patient comfort, diagnostic tools, and streamlined workflows for better care.

Key Takeaways

  • GE HealthCare and DeepHealth are integrating AI-driven SmartMammo with GE’s Senographe Pristina mammography system to improve imaging interpretation and patient comfort in breast cancer screening.
  • SmartMammo, a cloud-based AI tool, offers lesion localization, suspicion scoring, and prioritization capabilities, integrating with healthcare IT systems for efficient workflows.
  • The agreement allows GE HealthCare to distribute DeepHealth’s AI solutions in the U.S. and explore broader applications in other clinical areas.

——————————————————————————————————————————————————————————————————

GE HealthCare and DeepHealth, Inc., a RadNet subsidiary, are collaborating to advance AI-driven imaging solutions. Their partnership aims to enhance imaging interpretation, improve clinical insights, streamline team collaboration, and boost productivity by integrating GE HealthCare’s imaging expertise with DeepHealth’s AI technology.

In response to the rising demand for early cancer detection, the collaboration will integrate DeepHealth’s AI-based SmartMammo workflow with GE’s Senographe Pristina mammography system, enhancing breast cancer screening through AI support. The Senographe Pristina system was designed with patient comfort in mind, featuring soft, curved surfaces and ambient lighting, with 83% of patients rating it more comfortable.

Enhancing Breast Cancer Diagnostic Workflows

DeepHealth’s SmartMammo is a cloud-based AI solution for breast cancer diagnostic workflows. It includes:

  • A cloud-native image viewer with PACS functionality accessible from any location,
  • Integration with radiologist tools for streamlined workflow,
  • Clinical AI tools for automatic lesion localization and suspicion scoring, effective across diverse populations.

SmartMammo supports high-volume screening, enabling prioritization based on suspicion level, and integrates with healthcare IT systems. Its cloud-native setup allows for real-time updates and maintenance. The collaboration also includes Smart Alerts, a solution that rapidly identifies suspicious lesions, facilitating same-day diagnostics and reducing patient anxiety.

“We are thrilled to collaborate with GE HealthCare to accelerate AI-powered radiology,” said Kees Wesdorp, President and CEO of RadNet’s Digital Health division. “This partnership combines our DeepHealth OS and AI capabilities with GE’s imaging technology to streamline screening programs and improve patient outcomes.”

Personalize Cancer Care

Roland Rott, President and CEO of Imaging for GE HealthCare, adds, “This collaboration with DeepHealth strengthens our commitment to precision care. AI offers promising advancements in breast cancer screening, from early detection to streamlined workflows. We are excited to integrate imaging and AI for more personalized care.”

The agreement enables GE HealthCare to distribute SmartMammo and other DeepHealth solutions in the U.S. Both companies also plan to expand SmartTechnology solutions to other clinical areas, extending the reach of AI-driven healthcare solutions.

4o